Skip to main content
Log in

On the opinion of the European Commission “Scientific Committee on Food” regarding the tolerable upper intake level of vitamin E (2003)

  • LETTER TO THE EDITORS
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anderson TW, Reid DBW (1974) A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr 27:1174–1178

    Google Scholar 

  2. Bierenbaum ML, et al. (1985) The effect of supplemental vitamin E on serum parameters in diabetics, postcoronary and normal subjects. Nutr Res Int 31:1171–1180

    Google Scholar 

  3. Bursell SE, et al. (1999) High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245–1251

    CAS  PubMed  Google Scholar 

  4. FSA (Food Standards Agency) (2003) Expert Group on Vitamins and Minerals. Risk assessment of vitamin E, pp 145–154

  5. Gillilan RE, et al. (1977) Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 93:444–449

    Google Scholar 

  6. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart protection study of antioxidant vitamin supplementation in 20.536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23–32

    Article  PubMed  Google Scholar 

  7. Kim JM, White RH (1996) Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 77:545–546

    Article  Google Scholar 

  8. Leppälä JM, et al. (2000a) Controlled trial of a-tocopherol and b-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 20:230–235

    Google Scholar 

  9. Leppäla JM, et al. (2000b) Vitamin E and beta carotene supplementation in high risk for stroke. A subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol 57:1503–1509

    Article  Google Scholar 

  10. Meydani SN, et al. (1998) Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr 68:311–318

    Google Scholar 

  11. Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357:89–95

    Article  Google Scholar 

  12. Sano M,et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med 336:1216–1222

    Article  Google Scholar 

  13. SCF (Scientific Committee on Food) (2003) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin E

  14. Stephens NG, et al. (1996) Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786

    Article  CAS  PubMed  Google Scholar 

  15. Yusef S, et al. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes prevention Evaluation Study Investigators. N Engl J Med 342:154–160

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John K. Lodge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azzi, A., Brigelius-Flohé, R., Kelly, F. et al. On the opinion of the European Commission “Scientific Committee on Food” regarding the tolerable upper intake level of vitamin E (2003). Eur J Nutr 44, 60–62 (2005). https://doi.org/10.1007/s00394-005-0549-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-005-0549-8

Keywords

Navigation